Hap Trading, LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 11, 2021	SELL	$19.4 - $27.42 $147,440 - $208,392	-7,600 Reduced 38.97%	11,900 $28,000
Q1 2021 May 14, 2021	BUY	$25.02 - $54.99 $487,890 - $1.07 Million	19,500 New	19,500 $62,000
Q1 2020 May 08, 2020	SELL	$31.65 - $46.87 $414,615 - $613,997	-13,100 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$36.21 - $51.4 $474,351 - $673,340	13,100 New	13,100 $57,000
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $300,828 - $362,748	-12,900 Closed	0 $0

Q1 2019 May 10, 2019	SELL	$16.17 - $27.38 $114,807 - $194,398	-7,100 Reduced 35.5%	12,900 $27,000
Q4 2018 Feb 12, 2019	BUY	$14.32 - $22.92 $107,400 - $171,900	7,500 Added 60.0%	20,000 $5,000
Q3 2018 Nov 09, 2018	SELL	$13.03 - $21.81 $20,848 - $34,896	-1,600 Reduced 11.35%	12,500 $18,000
Q2 2018 Aug 13, 2018	BUY	$15.07 - $22.34 $212,487 - $314,994	14,100 New	14,100 $7,000

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.56B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.